ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 890

The Role of Adipocytokines in Osteophyte Formation in Osteoarthritis

Susann Junker1, Grit Krumbholz1, Klaus Frommer1, Angela Lehr2, Stefan Rehart3, Jürgen Steinmeyer4, Markus Rickert5, Georg A. Schett6, Ulf Müller-Ladner7 and Elena Neumann8, 1Department of Internal Medicine and Rheumatology, Kerckhoff-Klinik, Justus-Liebig-University of Giessen, Kerckhoff-Klinik, Bad Nauheim, Germany, 2Dept Orthopedics and Trauma Surgery, Markus-Hospital, Frankfurt, Germany, 3Orthopedics and Trauma Surgery, Markus-Hospital, Frankfurt, Germany, 4Dept of Orthopedics and Orthopedic Surgery, University Hospital Gießen and Marburg, Gießen, Germany, 5Dept of Orthopedics and Orthopedic Surgery, University Hospital Giessen and Marburg, Giessen, Germany, 6Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 7Internal Medicine and Rheumatology, Justus-Liebig-University of Gießen, Kerckhoff-Klinik, Bad Nauheim, Germany, 8Department of Internal Medicine and Rheumatology, Justus-Liebig-University of Gießen, Kerckhoff-Klinik, Bad Nauheim, Germany

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Adipocytokines, osteoarthritis and osteoblasts

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cytokines, Mediators, and Gene Regulation

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Obesity is an established risk factor in osteoarthritis (OA), but there is not much known about the interaction between bone formation and the so-called adipo(cyto)kines. Adipokines, such as adiponectin (Ad), visfatin (Vis) or resistin (Res), are adipose tissue-derived factors, which are associated with the pathogenesis of rheumatoid arthritis (RA) and OA. Adipokines can be produced by other cell types, e.g. fibroblasts, osteoblasts, osteoclasts and chondrocytes. However, in contrast to their joint-destructive effects in RA, their role in joint remodeling in OA, specifically in osteophyte formation, is still unclear. Therefore, the expression of adipokines in osteophyte development and cells of bone formation and their effect on these cells were analyzed.

Methods:

Osteophytes, cartilage and osteoblasts were obtained from OA patients during joint replacement surgery. Serial sections of bone tissue were stained (Masson trichrome, TRAP) and scored from grade one (no ossification, mainly connective tissue and cartilage) to five (ossified, mineralized osteophyte, <10% connective tissue). For analysis of adipokine localization, immunohistochemistry was performed to detect alkaline phosphatase, collagen-type II, Ad, Vis, and Res. Immunoassays for Vis were performed on cartilage and isolated primary chondrocyte lysates. Osteoblast cultures were stimulated with Ad or Res and measurements of IL-6, IL-8, and MCP-1 were performed in cell culture supernatants.

Results:

Ad, Res and Vis were detectable in all osteophyte grades. In osteophytes without ossification (grade 1), especially Ad and, to a lower extent, Res and Vis were localized in connective tissue fibroblasts. In ossified osteophytes (grade 2-5), Res and Vis protein expression was co-localized with osteoclasts and osteoblasts. Vis was detectable additionally in chondrocytes in osteophytes of all grades (50 % stained chondrocytes). Vis expression in human cartilage and cultured chondrocytes was confirmed on protein and mRNA level. Ad was detectable in co-localization with osteoblasts as well as around blood vessels.

Vis expression in osteoblasts was confirmed on mRNA level. Immunocytochemistry on cultured osteoblasts confirmed the expression of Ad, Res and Vis. Stimulation of osteoblasts with Ad and Res led to an increased IL-6, IL-8 and MCP-1 release when compared to unstimulated controls (Ad: 5,7-fold, 9,5-fold, 3,6-fold, respectively / Res: 1,7-fold, 1,6-fold, 1,3-fold, respectively). The immunomodulatory effect of Ad on osteoblasts was stronger than the effect of Res.

Conclusion:

The expression of Ad and Vis in osteophyte connective tissue and cartilage suggests an involvement in early osteophyte formation. Res and Vis expression by osteoblasts and osteoclasts in ossified osteophytes suggests a role in bone remodeling of osteophytes at later stages. Osteoblasts respond to the stimulation with Ad and Res with an increased secretion of inflammatory mediators. Therefore, adipokines are most likely involved in osteophyte formation at different stages of OA and affect different cell types of cartilage and bone formation.

Acknowledgement: Funded by the ANCYLOSS project of the German Ministry of Research and Education (BMBF).


Disclosure:

S. Junker,
None;

G. Krumbholz,
None;

K. Frommer,
None;

A. Lehr,
None;

S. Rehart,
None;

J. Steinmeyer,
None;

M. Rickert,
None;

G. A. Schett,
None;

U. Müller-Ladner,
None;

E. Neumann,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-role-of-adipocytokines-in-osteophyte-formation-in-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology